VistaSeq Hereditary Cancer-Specific Panels
Every patient comes from a different background with a unique personal and family history. Patients with a family history that is specific to one cancer type may receive more benefit from a focused panel test. Oncology offers several subpanel testing options for a more targeted approach to testing.
Click on test name for specimen requirements and additional information.
| VistaSeq Hereditary Cancer Tests by NGS | Test Code | Genes | |
|---|---|---|---|
| Hereditary Cancer - 27 multi-gene panel | 481220 | APC, ATM, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDK4, CDKN2A, CHEK2, EPCAM, FAM175A, MLH1, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, PRKAR1A, PTEN, RAD51C, RAD51D, SMAD4, STK11, TP53. | |
| Hereditary Cancer Panel without BRCA1/2 Genes | 481240 | APC, ATM, BARD1, BMPR1A, BRIP1, CDH1, CDK4, CDKN2A, CHEK2, EPCAM, FAM175A, MLH1, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, PRKAR1A, PTEN, RAD51C, RAD51D, SMAD4, STK11, TP53. | |
| APC Comprehensive Analysis | 483484 | APC | |
| Brain / CNS / PNS Cancer Panel | 481386 |
| |
| Breast and GYN Cancer Panel | 481341 | ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2,EPCAM, FAM175A, FANCC, MLH1, MRE11A, MSH2, MSH6, MUTYH, NBN, NF1, PALB2, PMS2, PTEN, RAD50, RAD51C, RAD51D, STK11, TP53 | |
| Breast Cancer Panel | 481319 | ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHECK2, FAM175A, MRE11A, MYTYG, NBN, NF1, PALB2, PTEN, RAD50, RAD51C, RAD51D, STK11, TP53 | |
| Colorectal Cancer Panel | 481363 | APC, ATM, AXIN2, BLM, BMPR1A, BRCA1, BRCA2, CDH1, CDKN2A, CHEK2, EPCAM, MLH1, MSH2, MSH6, MUTYH, PMS2, POLD1, POLE, PTEN, SMAD4, STK11, TP53 | |
| Endocrine Cancer Panel | 481374 | CDC73, MAX, MEN1, NF1, PRKAR1A, PTEN, RET, SDHB, SDHC, SDHD, TMEM127, TP53, VHL | |
| GYN Cancer Panel | 481330 | BRCA1, BRCA2, CHEK2, EPCAM, MHL1, MSH2, MSH6, MUTYH, PMS2, PTEN, TP53 | |
| High/Moderate Risk Breast Cancer Panel | 4481452 | ATM, BRCA1, BRCA2, CDH1, CHEK2, PALB2, PTEN, STK11, TP53 | |
| High Risk Colorectal Cancer Panel | 481352 | APC, EPCAM, MLH1, MSH2, MSH6, MUTYH, PMS2 | |
| Lynch Syndrome Panel | 483543 | MLH1, MSH2, MSH6, PMS2, EPCAM | |
| MEN1 Comprehensive Analysis | 483460 | MEN1 | |
| MLH1 Comprehensive Analysis | 483946 | MLH1 | |
| MSH2 Comprehensive Analysis | 483508 | MSH2 | |
| MSH6 Comprehensive Analysis | 483520 | MSH6 | |
| Pancreatic Cancer Panel | 481385 | APC, ATM, BRCA1, BRCA2, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PALB2, PMS2, STK11, TP53, VHL | |
| PMS2 Comprehensive Analysis | 483532 | PMS2 | |
| Prostate Cancer Panel | 483555 | ATM, BRCA1, BRCA2, CHEK2, HOXB13 (NGS only), MLH1, MSH2, MSH6, PALB2, PMS2 | |
| Renal Cell Cancer Panel | 481407 | EPCAM, FH, FLCN, GPC3, MET, MITF (c.952G>A), MLH1, MSH2, MSH6, PTEN, PMS2, SDHB, SDHC, SDHD, TP53, TSC1, TSC2, VHL, WT1 | |
| RET Comprehensive Analysis | 483472 | RET |
VistaSeq - summary of genes and commonly associated cancers
